Considering combination versus sequential chemotherapy in metastatic breast cancer

Both combination and sequential single-agent chemotherapy are reasonable options to treat metastatic breast cancer, but the choice between the two should ultimately be based on patient- and disease-related factors, according to a new commentary published online August 5 in the Journal of the National Cancer Institute.

Read the whole article on Physorg

More from Physorg